Skip to content

Efficacy of K-Y Jelly in Prevention of Postoperative Sore Throat After Nasal Surgery

Efficacy of K-Y Jelly in Prevention of Postoperative Sore Throat After Nasal Surgery

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05436743
Enrollment
140
Registered
2022-06-29
Start date
2022-07-01
Completion date
2022-08-31
Last updated
2022-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Sore Throat

Brief summary

Postoperative sore throat (POST) is a fairly common side effect of general anesthesia which is caused by the mucosal injury and nerve compression associated with tracheal intubation or laryngeal mask airway device insertion. In this randomized study, the authors evaluate the effect of K-Y jelly-soaked nasopharyngeal packs on POST and postoperative nausea and vomiting in patients subjected to nasal surgery.

Detailed description

Postoperative sore throat (POST) is a fairly common side effect of general anesthesia which is caused by the mucosal injury and nerve compression associated with tracheal intubation or laryngeal mask airway device insertion. In this randomized study, the authors evaluate the effect of K-Y jelly-soaked nasopharyngeal packs on POST and postoperative nausea and vomiting in patients subjected to nasal surgery. The present double-blinded randomized controlled study was conducted at Al-Azhar University Hospitals, Cairo, Egypt. The study protocol was approved by the local ethical committee of Al-Azhar Faculty of Medicine and all patients provided informed consent before enrollment in the study.

Interventions

DRUGK-Y Jelly, Topical Gel soaked packs

Topical Gel used as lubricant

OTHERWater soaked packs

Water soaked packs for reduction of postoperative sore throat

Sponsors

Alaa Gamal
Lead SponsorNETWORK

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients submitted to nasal surgery under general anesthesia.

Exclusion criteria

* Acute of chronic nasopharyngeal conditions, * Gastroesophageal reflux, regurgitation, * History of postoperative sore throat, * nasal surgery for malignant disease, * concurrent or recent use of systemic or topical agents used for sore throat or * Mallampati grade more than 2.

Design outcomes

Primary

MeasureTime frameDescription
Postoperative sore throatup to 6 hours postoperativelyPostoperative sore throat

Countries

Egypt

Contacts

Primary ContactAhmed Algarhy, PhD
Elgarhy_79@yahoo.com0 111 088 8332

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026